Positive headline results for AT278 clinical trial | Company Announcement
Investegate announcements from Positive headline results for AT278 clinical trial
Source: investegate.co.uk
Thomas Pieber News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Pieber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Pieber Today - Breaking & Trending Today
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
Arecor Therapeutics plc AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES AT278 demonstrates...
Source: marketscreener.com
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
Today, Boehringer Ingelheim and CBmed GmbH Center for Biomarker Research in Medicine (CBmed) announced a long-term strategic partnership. Jointly the partners will apply translational medicine approaches to accelerate the development of first-in-class medicines to transform the lives of people with cancer and ...
Source: pharmiweb.com
No Hypoglycemia With Once-Weekly Insulin? Questions Remain
Hypoglycemia rates didn't differ between weekly insulin icodec and daily glargine even when intentionally doubling and tripling the doses, although those parts of the study each lasted just 1 day.
Source: medscape.com
ARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CARE
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com